- The report contains detailed information about Bionor Pharma ASA that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Bionor Pharma ASA. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Bionor Pharma ASA financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Bionor Pharma ASA competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Bionor Pharma ASA business.
About Bionor Pharma ASA
Bionor Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases. It offers Nutrilett and NutriPro, which are health care products for weight management; and Abacor, a patented composition of isolated soy protein, soy isoflavones, cotyledon soy fiber, and phospholipids used for the reduction of cholesterol. The company also provides Nutri5, which is used for the treatment of menopausal and pre-menstrual symptoms; and NutriBar and Nutri Femme nutrition products. It has operations in the Nordic countries, Russia, and the Commonwealth of Independent States. The company was formerly known as Nutri Pharma ASA and changed its name to Bionor Pharma ASA on June 14, 2010. Bionor Pharma ASA was founded in 1993 and is based in Oslo, Norway.
RESEARCH METHODOLOGY
DISCLAIMER
1. BIONOR PHARMA ASA COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. BIONOR PHARMA ASA BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. BIONOR PHARMA ASA SWOT ANALYSIS
3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats
4. BIONOR PHARMA ASA FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. BIONOR PHARMA ASA COMPETITORS AND INDUSTRY ANALYSIS
5.1. Bionor Pharma ASA Direct Competitors
5.2. Comparison of Bionor Pharma ASA and Direct Competitors Financial Ratios
5.3. Comparison of Bionor Pharma ASA and Direct Competitors Stock Charts
5.4. Bionor Pharma ASA Industry Analysis
5.4.1. Healthcare Services Industry Snapshot
5.4.2. Bionor Pharma ASA Industry Position Analysis
6. BIONOR PHARMA ASA NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. BIONOR PHARMA ASA EXPERTS REVIEW*
7.1. Experts Opinion
7.2. Experts Estimates
APPENDIX 1: RATIO DEFINITIONS
LIST OF TABLES
Bionor Pharma ASA Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Bionor Pharma ASA Key Executives
Key Executives Biographies*
Key Executives Compensations*
Bionor Pharma ASA Major Shareholders
Bionor Pharma ASA History
Bionor Pharma ASA Products
Revenues by Product
Revenues by Region
Bionor Pharma ASA Offices and Representations
Bionor Pharma ASA SWOT Analysis
Income Statement 2009-2012 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2009-2012 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2009-2012 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Bionor Pharma ASA Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Bionor Pharma ASA Capital Market Snapshot
Bionor Pharma ASA Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Services Industry Statistics
Bionor Pharma ASA Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Bionor Pharma ASA Consensus Recommendations*
Analyst Recommendation Summary*
Price Target Summary*
Experts Recommendation Trends*
Revenue Estimates Analysis*
Earnings Estimates Analysis*
Historical Surprises*
Revenue Estimates Trend*
Earnings Estimates Trend*
Revenue Revisions*
Earnings Revisions*
LIST OF FIGURES
Bionor Pharma ASA Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Bionor Pharma ASA 1-year Stock Charts
Bionor Pharma ASA 5-year Stock Charts
Bionor Pharma ASA vs. Main Indexes 1-year Stock Chart
Bionor Pharma ASA vs. Direct Competitors 1-year Stock Charts
Bionor Pharma ASA Article Density Chart
* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.
The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.